$3.84 Billion is the total value of Perceptive Advisors's 113 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $349,343,000 | +34.0% | 11,670,057 | +23.9% | 9.10% | +75.8% |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS INC | $309,897,000 | -33.5% | 6,065,726 | +3.4% | 8.07% | -12.9% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $265,126,000 | -31.7% | 3,063,263 | -15.2% | 6.90% | -10.5% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $255,167,000 | -38.2% | 3,319,450 | +3.6% | 6.65% | -19.0% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $232,685,000 | -4.9% | 25,182,364 | +0.2% | 6.06% | +24.6% |
| BBIO | BRIDGEBIO PHARMA INC | $194,481,000 | +36.7% | 6,706,268 | 0.0% | 5.06% | +79.2% | |
| KOD | KODIAK SCIENCES INC | $174,752,000 | -33.7% | 3,663,557 | 0.0% | 4.55% | -13.1% | |
| ZYME | Buy | ZYMEWORKS INC | $126,092,000 | +15.4% | 3,560,999 | +48.2% | 3.28% | +51.3% |
| NVRO | Buy | NEVRO CORP | $107,449,000 | +19.7% | 1,092,068 | +43.0% | 2.80% | +56.8% |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $94,078,000 | -26.8% | 3,484,358 | +4.4% | 2.45% | -4.0% |
| ATNX | ATHENEX INC | $89,261,000 | -49.3% | 11,532,467 | 0.0% | 2.32% | -33.5% | |
| MGTX | MEIRAGTX HOLDINGS PLC | $86,463,000 | -32.9% | 6,433,277 | 0.0% | 2.25% | -12.0% | |
| ZGNX | Sell | ZOGENIX INC | $85,390,000 | -55.8% | 3,452,921 | -6.9% | 2.22% | -42.1% |
| KDMN | Buy | KADMON HOLDINGS INC | $65,830,000 | -0.7% | 15,711,334 | +7.3% | 1.72% | +30.2% |
| MYOK | Buy | MYOKARDIA INC | $61,611,000 | -29.9% | 1,314,209 | +8.9% | 1.60% | -8.1% |
| FREQ | FREQUENCY THERAPEUTICS INC | $54,040,000 | +8.5% | 3,034,296 | 0.0% | 1.41% | +42.3% | |
| QTNT | QUOTIENT LTD | $52,491,000 | -58.5% | 13,289,054 | 0.0% | 1.37% | -45.5% | |
| ADMA | Buy | ADMA BIOLOGICS INC | $47,764,000 | +3.6% | 16,584,802 | +44.0% | 1.24% | +36.0% |
| VBIV | VBI VACCINES INC | $43,653,000 | -31.2% | 45,951,556 | 0.0% | 1.14% | -9.8% | |
| RTRX | RETROPHIN INC | $42,173,000 | +2.7% | 2,890,608 | 0.0% | 1.10% | +34.7% | |
| BPMC | Buy | BLUEPRINT MEDICINES CORP | $40,271,000 | -18.7% | 688,624 | +11.3% | 1.05% | +6.6% |
| REGN | New | REGENERON PHARMACEUTICALS INC | $39,063,000 | – | 80,000 | +100.0% | 1.02% | – |
| CRNX | CRINETICS PHARMACEUTICALS INC | $38,042,000 | -41.4% | 2,587,953 | 0.0% | 0.99% | -23.2% | |
| VRCA | VERRICA PHARMACEUTICALS INC | $37,275,000 | -28.3% | 3,410,412 | 0.0% | 0.97% | -6.0% | |
| New | RETROPHIN INCnote 2.500% 9/1 | $35,016,000 | – | 45,000,000 | +100.0% | 0.91% | – | |
| EIDX | Sell | EIDOS THERAPEUTICS INC | $33,652,000 | -15.9% | 686,922 | -1.5% | 0.88% | +10.2% |
| MTEM | MOLECULAR TEMPLATES INC | $32,882,000 | -5.0% | 2,474,133 | 0.0% | 0.86% | +24.6% | |
| ALBO | Buy | ALBIREO PHARMA INC | $31,931,000 | -26.3% | 1,960,139 | +15.0% | 0.83% | -3.4% |
| AGIO | AGIOS PHARMACEUTICALS INC | $31,860,000 | -25.9% | 900,000 | 0.0% | 0.83% | -2.8% | |
| VAPO | Sell | VAPOTHERM INC | $31,447,000 | +48.3% | 1,670,067 | -4.2% | 0.82% | +94.5% |
| RCKT | Sell | ROCKET PHARMACEUTICALS INC | $30,537,000 | -40.1% | 2,189,010 | -2.2% | 0.80% | -21.4% |
| ALLO | ALLOGENE THERAPEUTICS INC | $30,011,000 | -25.2% | 1,543,790 | 0.0% | 0.78% | -1.9% | |
| AGRX | Buy | AGILE THERAPEUTICS INC | $29,611,000 | -0.6% | 15,919,325 | +33.6% | 0.77% | +30.2% |
| DBVT | Buy | DBV TECHNOLOGIES SAsponsored adr | $28,685,000 | -38.6% | 7,317,809 | +67.5% | 0.75% | -19.5% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $28,356,000 | -34.5% | 675,129 | -29.2% | 0.74% | -14.1% |
| PRVB | Buy | PROVENTION BIO INC | $27,707,000 | -36.4% | 3,011,574 | +3.1% | 0.72% | -16.5% |
| BDTX | New | BLACK DIAMOND THERAPEUTICS INC | $27,561,000 | – | 1,104,656 | +100.0% | 0.72% | – |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $25,339,000 | +192.3% | 1,551,722 | +268.3% | 0.66% | +283.7% |
| CTMX | CYTOMX THERAPEUTICS INC | $24,958,000 | -7.7% | 3,253,923 | 0.0% | 0.65% | +21.0% | |
| TBPH | New | THERAVANCE BIOPHARMA INC | $23,110,000 | – | 1,000,000 | +100.0% | 0.60% | – |
| UROV | Sell | UROVANT SCIENCES LTD | $21,823,000 | -41.5% | 2,366,831 | -1.7% | 0.57% | -23.5% |
| CNCE | CONCERT PHARMACEUTICALS INC | $19,549,000 | -1.5% | 2,150,641 | 0.0% | 0.51% | +29.2% | |
| MNLO | New | MENLO THERAPEUTICS INC | $17,456,000 | – | 6,637,179 | +100.0% | 0.46% | – |
| RGNX | Sell | REGENXBIO INC | $17,145,000 | -31.2% | 508,000 | -16.4% | 0.45% | -9.7% |
| SOLID BIOSCIENCES INC | $16,132,000 | -46.3% | 6,749,803 | 0.0% | 0.42% | -29.6% | ||
| NEPT | NEPTUNE WELLNESS SOLUTIONS INC | $15,721,000 | -57.2% | 13,436,906 | 0.0% | 0.41% | -44.0% | |
| TPTX | Sell | TURNING POINT THERAPEUTICS INC | $15,441,000 | -43.3% | 349,890 | -20.0% | 0.40% | -25.7% |
| STOK | STOKE THERAPEUTICS INC | $15,388,000 | -19.1% | 671,978 | 0.0% | 0.40% | +6.1% | |
| DNLI | New | DENALI THERAPEUTICS INC | $14,884,000 | – | 850,000 | +100.0% | 0.39% | – |
| TXG | 10X GENOMICS INC | $13,816,000 | -17.6% | 220,000 | 0.0% | 0.36% | +8.1% | |
| PODD | New | INSULET CORP | $13,708,000 | – | 82,733 | +100.0% | 0.36% | – |
| RVNC | Buy | REVANCE THERAPEUTICS INC | $13,690,000 | +2.8% | 925,000 | +12.8% | 0.36% | +35.2% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES CORP | $13,424,000 | +47.1% | 495,000 | +62.3% | 0.35% | +93.4% |
| ESTA | Sell | ESTABLISHMENT LABS HOLDINGS INC | $13,332,000 | -54.1% | 922,633 | -12.2% | 0.35% | -39.9% |
| ALEC | ALECTOR INC | $12,348,000 | +40.0% | 511,731 | 0.0% | 0.32% | +84.0% | |
| YMAB | Sell | Y-MABS THERAPEUTICS INC | $12,085,000 | -31.2% | 522,480 | -7.1% | 0.32% | -9.7% |
| GILD | New | GILEAD SCIENCES INC | $11,214,000 | – | 1,500,000 | +100.0% | 0.29% | – |
| LPTX | New | LEAP THERAPEUTICS INC | $10,627,000 | – | 6,726,496 | +100.0% | 0.28% | – |
| SDGR | New | SCHRODINGER INC | $10,545,000 | – | 250,000 | +100.0% | 0.28% | – |
| TWST | Buy | TWIST BIOSCIENCE CORP | $10,380,000 | +129.0% | 322,356 | +49.3% | 0.27% | +200.0% |
| VCRA | Buy | VOCERA COMMUNICATIONS INC | $10,298,000 | +67.3% | 470,000 | +58.6% | 0.27% | +119.7% |
| ATRC | New | ATRICURE INC | $10,152,000 | – | 302,227 | +100.0% | 0.26% | – |
| SCPEU | SC HEALTH CORPunit 99/99/9999 | $10,000,000 | -3.5% | 1,000,000 | 0.0% | 0.26% | +26.2% | |
| MORF | MORPHIC HOLDING INC | $9,542,000 | -14.5% | 650,000 | 0.0% | 0.25% | +12.2% | |
| HCAT | Buy | HEALTH CATALYST INC | $8,375,000 | -14.9% | 328,698 | +15.9% | 0.22% | +11.2% |
| RVMD | New | REVOLUTION MEDICINES INC | $7,816,000 | – | 350,000 | +100.0% | 0.20% | – |
| ALDX | ALDEYRA THERAPEUTICS INC | $7,621,000 | -57.5% | 3,085,458 | 0.0% | 0.20% | -44.4% | |
| IMVTU | IMMUNOVANT INCunit 12/18/2024 | $7,356,000 | -26.1% | 400,000 | 0.0% | 0.19% | -3.0% | |
| FULC | FULCRUM THERAPEUTICS INC | $7,164,000 | -28.2% | 600,000 | 0.0% | 0.19% | -5.6% | |
| ANAB | Sell | ANAPTYSBIO INC | $7,070,000 | -56.5% | 500,000 | -50.0% | 0.18% | -43.0% |
| CERN | CERNER CORP | $6,745,000 | -12.5% | 105,000 | 0.0% | 0.18% | +15.0% | |
| SILK | New | SILK ROAD MEDICAL INC | $6,639,000 | – | 204,600 | +100.0% | 0.17% | – |
| MYL | New | MYLAN N.V. | $6,028,000 | – | 400,000 | +100.0% | 0.16% | – |
| VRAY | VIEWRAY INC | $5,713,000 | -44.8% | 2,451,748 | 0.0% | 0.15% | -27.7% | |
| NLTX | NEOLEUKIN THERAPEUTICS INC | $5,535,000 | -10.1% | 500,000 | 0.0% | 0.14% | +18.0% | |
| VERU | VERU INC REGISTERED SHS | $5,396,000 | -2.4% | 1,650,000 | 0.0% | 0.14% | +28.2% | |
| TBIO | TRANSLATE BIO INC | $4,994,000 | +41.0% | 435,000 | 0.0% | 0.13% | +85.7% | |
| ZBH | ZIMMER BIOMET HOLDINGS INC | $4,914,000 | -34.3% | 50,000 | 0.0% | 0.13% | -14.1% | |
| MEIP | New | MEI PHARMA INC | $4,879,000 | – | 3,030,440 | +100.0% | 0.13% | – |
| ISEE | Buy | IVERIC BIO INC | $4,738,000 | -44.2% | 1,377,289 | +39.1% | 0.12% | -27.2% |
| IDYA | IDEAYA BIOSCIENCES INC | $4,702,000 | -45.1% | 1,141,484 | 0.0% | 0.12% | -28.2% | |
| Sell | AQUESTIVE THERAPEUTICS INC | $3,833,000 | -70.7% | 1,750,000 | -22.2% | 0.10% | -61.5% | |
| ONEM | New | 1LIFE HEALTHCARE INC | $3,310,000 | – | 185,000 | +100.0% | 0.09% | – |
| New | DERMTECH INC | $3,215,000 | – | 285,856 | +100.0% | 0.08% | – | |
| GRTX | GALERA THERAPEUTICS INC | $3,088,000 | -27.8% | 325,000 | 0.0% | 0.08% | -5.9% | |
| ABEO | ABEONA THERAPEUTICS INC | $3,060,000 | -37.6% | 1,500,000 | 0.0% | 0.08% | -17.5% | |
| LSACU | New | LIFESCI ACQUISITION CORPunit 3/31/2025 | $2,940,000 | – | 300,000 | +100.0% | 0.08% | – |
| MOTS | MOTUS GI HLDGS INC | $2,837,000 | -70.6% | 4,210,542 | 0.0% | 0.07% | -61.5% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $2,600,000 | -33.7% | 170,859 | 0.0% | 0.07% | -12.8% | |
| ATEC | ALPHATEC HOLDINGS INC | $2,021,000 | -49.3% | 561,574 | 0.0% | 0.05% | -32.9% | |
| PHR | PHREESIA INC | $1,424,000 | -23.6% | 70,000 | 0.0% | 0.04% | 0.0% | |
| BIO | Sell | BIO-RAD LABORATORIES INC | $1,218,000 | -95.2% | 3,489 | -94.9% | 0.03% | -93.6% |
| TXMD | THERAPEUTICSMD INC | $1,173,000 | -55.8% | 1,096,101 | 0.0% | 0.03% | -41.5% | |
| AXNX | Sell | AXONICS MODULATION TECHNOLOGIES INC | $1,188,000 | -22.0% | 50,000 | -9.1% | 0.03% | +3.3% |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $951,000 | -54.4% | 139,890 | 0.0% | 0.02% | -39.0% | |
| RACE | FERRARI N.V. | $957,000 | -6.7% | 6,200 | 0.0% | 0.02% | +25.0% | |
| MNTA | Sell | MOMENTA PHARMACEUTICALS INC | $881,000 | -98.4% | 30,637 | -98.9% | 0.02% | -97.9% |
| ZGNX | New | ZOGENIX INCput | $724,000 | – | 300,000 | +100.0% | 0.02% | – |
| SRRA | New | SIERRA ONCOLOGY INC | $664,000 | – | 66,654 | +100.0% | 0.02% | – |
| XLRN | New | ACCELERON PHARMA INC | $583,000 | – | 6,813 | +100.0% | 0.02% | – |
| KRMD | REPRO MED SYS INC | $537,000 | +9.8% | 74,813 | 0.0% | 0.01% | +40.0% | |
| New | LUMINEX CORP | $500,000 | – | 18,926 | +100.0% | 0.01% | – | |
| KRTX | KARUNA THERAPEUTICS INC | $497,000 | -5.0% | 6,944 | 0.0% | 0.01% | +30.0% | |
| CCXI | New | CHEMOCENTRYX INC | $406,000 | – | 10,252 | +100.0% | 0.01% | – |
| CUE | New | CUE BIOPHARMA INC | $362,000 | – | 26,371 | +100.0% | 0.01% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $327,000 | – | 11,418 | +100.0% | 0.01% | – |
| TARA | New | ARTARA THERAPEUTICS INC | $184,000 | – | 8,543 | +100.0% | 0.01% | – |
| MREO | MEREO BIOPHARMA GROUP PLCads | $187,000 | -68.2% | 179,419 | 0.0% | 0.01% | -58.3% | |
| SPY | New | SPDR S&P 500 ETF TRcall | $159,000 | – | 325,000 | +100.0% | 0.00% | – |
| MRTX | New | MIRATI THERAPEUTICS INCput | $149,000 | – | 100,000 | +100.0% | 0.00% | – |
| AVDL | AVADEL PHARMACEUTICALS PLCadr | $76,000 | +15.2% | 8,681 | 0.0% | 0.00% | +100.0% | |
| OTLKW | OUTLOOK THERAPEUTICS INCw exp 02/18/202 | $46,000 | +39.4% | 420,875 | 0.0% | 0.00% | 0.0% | |
| BGNE | Exit | BEIGENE LTDput | $0 | – | -200,000 | -100.0% | 0.00% | – |
| TORC | RESTORBIO INC | $10,000 | -28.6% | 9,306 | 0.0% | 0.00% | – | |
| PRTO | Exit | PROTEON THERAPEUTICS INC | $0 | – | -341,743 | -100.0% | -0.00% | – |
| CNST | Exit | CONSTELLATION PHARMCETICLS INC | $0 | – | -6,000 | -100.0% | -0.01% | – |
| ARAV | Exit | ARAVIVE INC | $0 | – | -32,895 | -100.0% | -0.01% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -11,256 | -100.0% | -0.01% | – |
| NTRA | Exit | NATERA INC | $0 | – | -14,549 | -100.0% | -0.01% | – |
| OPTN | Exit | OPTINOSE INC | $0 | – | -58,005 | -100.0% | -0.01% | – |
| ZYNE | Exit | ZYNERBA PHARMACEUTICALS INCput | $0 | – | -200,000 | -100.0% | -0.02% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -36,496 | -100.0% | -0.02% | – |
| NVCR | Exit | NOVOCURE LTD | $0 | – | -9,489 | -100.0% | -0.02% | – |
| SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -2,666,190 | -100.0% | -0.02% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS INC | $0 | – | -14,326 | -100.0% | -0.02% | – |
| SIC | Exit | SELECT INTERIOR CONCEPTS INC | $0 | – | -105,105 | -100.0% | -0.02% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -54,645 | -100.0% | -0.02% | – |
| SWAV | Exit | SHOCKWAVE MED INC | $0 | – | -30,000 | -100.0% | -0.03% | – |
| CRY | Exit | CRYOLIFE INC | $0 | – | -50,000 | -100.0% | -0.03% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -1,000,000 | -100.0% | -0.03% | – |
| ARWR | Exit | ARROWHEAD PHARMACEUTICALS INC | $0 | – | -30,738 | -100.0% | -0.04% | – |
| ACST | Exit | ACASTI PHARMA INC | $0 | – | -1,779,882 | -100.0% | -0.09% | – |
| NVTA | Exit | INVITAE CORP | $0 | – | -336,308 | -100.0% | -0.11% | – |
| Exit | MEI PHARMA INC | $0 | – | -4,400,440 | -100.0% | -0.22% | – | |
| ICPT | Exit | INTERCEPT PHARMACEUTICALS INC | $0 | – | -97,600 | -100.0% | -0.24% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -716,666 | -100.0% | -0.29% | – |
| ARVN | Exit | ARVINAS INC | $0 | – | -400,000 | -100.0% | -0.33% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -310,000 | -100.0% | -0.37% | – |
| EHTH | Exit | EHEALTH INC | $0 | – | -197,720 | -100.0% | -0.38% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INCcall | $0 | – | -800,600 | -100.0% | -0.57% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -11,203,881 | -100.0% | -0.74% | – |
| AMRN | Exit | AMARIN CORPORATION PLCspons adr new | $0 | – | -7,106,079 | -100.0% | -3.03% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-05-18
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.